News Release

<< Back

Sunesis Pharmaceuticals to Present at BMO Capital Markets 10th Annual Focus on Healthcare Investor Conference

08/03/10

SOUTH SAN FRANCISCO, CA, Aug 03, 2010 (MARKETWIRE via COMTEX News Network) -- Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS), a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers, today announced that Eric Bjerkholt, Senior Vice President, Corporate Development and Finance, will be presenting at the BMO Capital Markets 10th Annual Focus on Healthcare Investor Conference on Thursday, August 5, 2010 at 11:15 A.M. Eastern Time at the Sheraton New York Hotel & Towers in New York City.

A live webcast of this presentation will be available on the Sunesis website at http://ir.sunesis.com. A replay of the webcast will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks.

About Sunesis Pharmaceuticals

Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, voreloxin, in multiple indications to improve the lives of people with cancer. For additional information on Sunesis Pharmaceuticals, please visit http://www.sunesis.com.

Investor and Media Inquiries:

David Pitts
Argot Partners
212-600-1902

Eric Bjerkholt
Sunesis Pharmaceuticals Inc.
650-266-3717


SOURCE: Sunesis Pharmaceuticals, Inc.


Copyright 2010 Marketwire, Inc., All rights reserved.

News Provided by COMTEX